SHIELD THERAPEUTICS PLC Logo

SHIELD THERAPEUTICS PLC

STX | IL

Overview

Corporate Details

ISIN(s):
GB00BYV81293
LEI:
213800G74QWY15FC3W71
Country:
United Kingdom
Address:
NORTHERN DESIGN CENTRE STUDIO 6, 3RD FLOOR, NE8 3DF GATESHEAD
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company focused on addressing the significant unmet medical need for patients with iron deficiency. The company's lead product is ACCRUFeR® (ferric maltol), a novel, stable, non-salt-based oral therapy for adults suffering from iron deficiency, with or without anemia. Shield Therapeutics is dedicated to the commercialization of its innovative treatments to improve the lives of patients across multiple therapeutic categories.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for SHIELD THERAPEUTICS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 13:06
Earnings Release
Interim results for the six months ended 30 Jun 25
English 245.5 KB
2025-05-22 11:40
Annual Report
Shield Therapeutics plc 2024 Annual Report and Accounts
English 4.4 MB
2025-04-22 08:01
Business and Financial Review
Licence Agreement in Japan for ACCRUFeR®
English 22.9 KB
2025-03-11 08:00
Regulatory News Service
ACCRUFeR® launched in Canada
English 21.0 KB
2025-02-13 17:15
Director's Dealing
PDMR Transaction Notification
English 28.6 KB
2025-02-13 08:00
Remuneration Information
Grant of Share Options
English 28.1 KB
2025-02-05 08:00
Earnings Release
Unaudited full year trading update
English 22.4 KB
2025-01-27 08:00
Board/Management Information
Anders Lundstrom appointed CEO
English 18.7 KB
2024-12-24 12:25
Post-Annual General Meeting Information
Result of General Meeting & Total Voting Rights
English 27.9 KB
2024-12-23 08:00
Share Issue/Capital Change
Results of RetailBook Offer
English 20.0 KB
2024-12-06 12:31
Share Issue/Capital Change
RetailBook Offer
English 31.8 KB
2024-12-06 12:30
Share Issue/Capital Change
Subscription by AOP Health to raise US$10 million
English 190.9 KB
2024-11-21 08:00
Regulatory News Service
Business Update
English 21.1 KB
2024-10-29 08:00
Earnings Release
Q3 Trading Update
English 27.7 KB
2024-09-25 08:00
Regulatory News Service
Results from Phase 3 paediatric study
English 23.6 KB

Automate Your Workflow. Get a real-time feed of all SHIELD THERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SHIELD THERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK